2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
129
Colonic Neoplasms
54
Rectal Neoplasms
48
Carcinoma, Hepatocellular
29
Stomach Neoplasms
23
Neoplasm Metastasis
23
Neoplasms
11
Pancreatic Neoplasms
10
Cholangiocarcinoma
9
Adenocarcinoma Of Esophagus
8
Esophageal Neoplasms
7
Liver Neoplasms
6
Gastrointestinal Neoplasms
5
Biliary Tract Neoplasms
5
Recurrence
4
Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Digestive System Neoplasms
3
Breast Neoplasms
3
Adenocarcinoma
3
Unresectable Metastatic Colorectal Cancer
2
Peritoneal Neoplasms
2
Neurotoxicity Syndromes
2
Neoplastic Cells, Circulating
2
Intestinal Neoplasms
2
Gastrointestinal Diseases
2
Gallbladder Neoplasms
2
Colorectal Cancer Metastatic
2
Cirrhosis, Familial, with Pulmonary Hypertension
2
Interventions
Capecitabine
20
Oxaliplatin
13
Irinotecan
8
spartalizumab
6
tislelizumab
4
Radiation
4
Neoadjuvant Therapy
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
sintilimab
2
camrelizumab
2
Radiotherapy
2
Leucovorin
2
Celecoxib
2
veliparib
1
peposertib
1
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Rectal Cancer
×
Folfox protocol
×
Clear all
NCT07074353
2025-07-25
CinClare-2
Zhejiang Cancer Hospital
Phase 3
Not yet recruiting
360 enrolled